All Pathways
Trauma SurgeryEmergency

Hemorrhagic Shock & Damage Control Resuscitation

Hemorrhagic Shock & Damage Control Resuscitation: Hemorrhagic Shock Identified → Classify Shock Severity → Class I-II: Crystalloid Trial → Damage Contro...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Hemorrhagic Shock Identified

    Signs of hemorrhagic shock in trauma patient

    1. Decision

      Classify Shock Severity

      Assess hemorrhage class

      • Class I: <15% blood loss, HR normal, BP normal
      • Class II: 15-30%, HR 100-120, BP normal, RR 20-30
      • Class III: 30-40%, HR 120-140, BP decreased, confused
      • Class IV: >40%, HR >140, BP very low, lethargic
      1. Action

        Class I-II: Crystalloid Trial

        Initial fluid resuscitation

        • 1-2L warm crystalloid (LR preferred)
        • Reassess response
        • Type and screen blood
        • Monitor for progression
        1. Action

          Damage Control Resuscitation

          Core DCR principles

          • PERMISSIVE HYPOTENSION: SBP 80-90 mmHg until surgical control
          • HEMOSTATIC RESUSCITATION: 1:1:1 ratio (or whole blood)
          • Limit crystalloid (<2L total)
          • Avoid hypothermia and acidosis
          • Target: Lethal triad prevention
          1. Action

            Tranexamic Acid (TXA)

            Give within 3 hours of injury

            • 1g IV bolus over 10 minutes
            • Then 1g IV infusion over 8 hours
            • Most benefit if given <1 hour
            • Do NOT give if >3 hours from injury
            1. Action

              Prevent Lethal Triad

              Target hypothermia, acidosis, coagulopathy

              • HYPOTHERMIA: Warm fluids, forced-air warming, target >36°C
              • ACIDOSIS: Treat with perfusion, avoid excessive crystalloid
              • COAGULOPATHY: Balanced blood products, calcium replacement
              • Calcium chloride 1g IV per 4 units blood (counter citrate)
              1. Decision

                TEG/ROTEM Available?

                Goal-directed coagulation management

                1. Action

                  TEG/ROTEM-Guided Therapy

                  Targeted product replacement

                  • Prolonged R/CT (clot initiation): Give FFP
                  • Low α-angle/K (fibrinogen): Give cryoprecipitate (10 units)
                  • Low MA/MCF (platelet function): Give platelets
                  • Fibrinolysis (LY30 >3%): Consider additional TXA
                  1. Decision

                    Hemorrhage Controlled?

                    Surgical or procedural hemostasis achieved

                    1. Warning

                      Continue DCR → OR/IR

                      Hemorrhage not controlled

                      • Emergent surgical intervention
                      • Consider IR angioembolization
                      • REBOA for non-compressible torso hemorrhage
                      • Damage control surgery (pack and return)
                    2. Action

                      Post-DCR Management

                      Transition to definitive care

                      • Deactivate MTP when hemorrhage controlled
                      • Warm patient to normothermia
                      • Correct residual coagulopathy
                      • Monitor for abdominal compartment syndrome
                      • Plan for definitive surgery (24-48h)
                      1. Outcome

                        Hemorrhage Controlled, Resuscitation Complete

                        Patient stabilized for ICU care

                2. Action

                  Empiric Lab-Guided

                  Without viscoelastic testing

                  • Check CBC, PT/INR, PTT, fibrinogen q30-60min
                  • Continue 1:1:1 ratio empirically
                  • Target: Plt >50K, INR <1.5, Fib >1.5 g/L
                  • Consider cryoprecipitate if fibrinogen <1.5
          2. Action

            Blood Product Administration

            Balanced resuscitation

            • Whole blood if available (preferred)
            • Or 1:1:1 ratio RBC:FFP:Platelets
            • Use rapid infuser/blood warmer
            • Target: Hgb >7, Plt >50K, INR <1.5
            • Fibrinogen >1.5 g/L
      2. Warning

        Class III-IV: Activate MTP

        Severe hemorrhage - immediate MTP

        • Activate massive transfusion protocol
        • Call blood bank immediately
        • Notify OR/trauma surgery
        • Type O blood if uncrossmatched needed

Guideline Source

WTA Critical Decisions: Damage Control Resuscitation 2025

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Blood product availability varies by institution
  • TEG/ROTEM availability varies
  • Does not replace surgical hemorrhage control
  • Specific product ratios may vary by protocol

Applicable Regions

USEUGlobal

EU: Component therapy ratios may vary

US: Whole blood increasingly available at level 1 trauma centers

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Hemorrhagic Shock & Damage Control Resuscitation?

The Hemorrhagic Shock & Damage Control Resuscitation is a emergency clinical algorithm for Trauma Surgery. It provides a structured decision tree to guide clinical decision-making, based on WTA Critical Decisions: Damage Control Resuscitation 2025.

What guideline is the Hemorrhagic Shock & Damage Control Resuscitation based on?

This algorithm is based on WTA Critical Decisions: Damage Control Resuscitation 2025 (DOI: 10.1097/TA.0000000000004088).

What are the limitations of the Hemorrhagic Shock & Damage Control Resuscitation?

Known limitations include: Blood product availability varies by institution; TEG/ROTEM availability varies; Does not replace surgical hemorrhage control; Specific product ratios may vary by protocol. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Hemorrhagic Shock & Damage Control Resuscitation appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free